Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?


Creative Commons License

Dirican A., Kucukzeybek B. B. , Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., ...Daha Fazla

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.20, ss.70-81, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s10147-014-0672-8
  • Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • Sayfa Sayıları: ss.70-81

Özet

Background The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with cancer. Similarly, a study in a large series has shown that the newly defined derived NLR (dNLR; neutrophil/leukocyte-lymphocyte ratio) also has prognostic value. The present study retrospectively evaluates the prognostic significance of NLR and dNLR in breast cancer.